JP Morgan Maintains Overweight on Enovix, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
JP Morgan analyst Bill Peterson maintains an Overweight rating on Enovix (NASDAQ:ENVX) but lowers the price target from $18 to $12.
April 26, 2024 | 1:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
JP Morgan maintains an Overweight rating on Enovix but lowers the price target from $18 to $12.
The reduction in price target by JP Morgan, despite maintaining an Overweight rating, could lead to short-term negative sentiment among investors, potentially impacting the stock price negatively.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100